Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Gynecologic 2

Conditions

Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia 11Lymphoma, Mantle-Cell 10Lymphoma, B-Cell, Marginal Zone 10Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Acute 8Congenital Abnormalities 8Burkitt Lymphoma 8Rectal Neoplasms 7Hodgkin Disease 7Head and Neck Neoplasms 7Multiple Myeloma 6Melanoma 6Colonic Neoplasms 6Carcinoma, Renal Cell 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 4

Interventions

Colposcopy 15Imiquimod 13Conization 11Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Papillomavirus Vaccines 6Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Watchful Waiting 4Human Papillomavirus DNA Tests 4Vaccines 3Blood Specimen Collection 3VGX-3100 2Transurethral Resection of Prostate 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Mass Screening 2Indomethacin 2Human Papillomavirus Recombinant Vaccine nonavalent 2High-Throughput Screening Assays 2GX-188 vaccine 2Fluorouracil 2Flow Cytometry 2Cyclophosphamide 2Curcumin 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Dysplasia × Polymerase Chain Reaction × Clear all
NCT00667563 2024-03-19

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

AIDS Malignancy Consortium

Phase 1 Completed
150 enrolled 12 charts
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡